| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0004 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |